The following video is from Monday's edition of Investor Beat, in which host Alison Southwick and Motley Fool analysts Jason Moser and Matt Argersinger dissect the hardest-hitting investing stories of the day.
The Active Network (NYSE:ACTV) is going private. Facebook (NASDAQ:FB) has a new customer. Achilleon Pharmaceuticals (NASDAQ:ACHN) gets devastating news for a hepatitis C drug. And AMC Networks (NASDAQ:AMCX) shows with its Breaking Bad finale that content is still king. In this segment from Investor Beat, Jason and Matt discuss four stocks making moves on Wednesday.
Alison Southwick and Jason Moser have no position in any stocks mentioned. Matthew Argersinger owns shares of Netflix and is also short December 2013 $250 calls on Netflix. The Motley Fool recommends AMC Networks, Facebook, Netflix, and The Active Network and owns shares of Facebook and Netflix. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Here's Why Achillion Pharmaceuticals Is Soaring 19.5% Today
The company's story is finally untied from its failed relationship with Johnson & Johnson.
Why Achillion Pharmaceuticals Stock Is Falling Today
Johnson & Johnson reportedly plans to dump its entire stake in Achillion Pharmaceuticals through a public offering.
Why Achillion Pharmaceuticals Crashed 22.2% Today
Johnson & Johnson is walking away from its agreement to develop Achillion Pharmaceuticals' hepatitis C drugs.